About Bioskin
Bioskin is a Healthcare company based in Hamburg (Germany) founded in 1992, and was acquired by Eurofins Scientific in August 2021. Dermatology CRO offering clinical trial services for drugs, medical devices, food supplements and advanced cosmetics. Bioskin offers products and services including Dermatologic Consulting, Clinical Development, and Global Trials. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is Eurofins bioskin GmbH. Its competitors include SIT Skin Investigation and Technology and SCIderm.
Company details
Bioskins service portfolio includes strategic and regulatory consulting for dermatology, ophthalmology and womens health products, early phase safety and Proof-of-Concept studies, vasoconstrictor assays and global Phase II-IV trials for NCEs, new formulations with known actives and generics. They offer services such as efficacyproof of concept, project management, data operations, quality management, and medical writing etc., They claim to maintain a database of patients and healthy volunteers with skin conditions and diseases in Europe. They also claim to have the capability for developing innovative test models and integrating biophysical measurements to deliver data about skin function and structure to support clinical endpoints. They also have partnerships with other companies in US, Latin America, South Africa and few others to conduct multinational studies.
- Headquarters Hamburg, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website bioskincro.com
- Social LinkedIn
- Acquired by Eurofins Scientific (Aug 2021)
- Legal Name Eurofins Bioskin Gmbh
- Investors
- Acquired byEurofins Scientific
(Aug 2021)
Products & Services of Bioskin
Bioskin offers a comprehensive portfolio of products and services, including Dermatologic Consulting, Clinical Development, and Global Trials.
Strategic and regulatory advice for dermatology products and trials
Early-phase safety and Proof-of-Concept studies for new formulations
Phase II-IV trials for NCEs, generics, and international partnering
Investors in Bioskin
Bioskin has secured backing from 1 investor. Prominent investors backing the company include Eurofins Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Laboratory testing and contract research services are provided globally. | 1987 | eurofins.com | Luxembourg, Luxembourg |
Investor details for Bioskin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bioskin
2 dated milestones of Bioskin across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Bioskin is founded.
- Exit Acquired by Eurofins Scientific.
Competitors of Bioskin
Bioskin has 2 listed competitors in our database. They include SIT Skin Investigation and Technology and SCIderm.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sit-skin.de | 1997 | Hamburg, Germany | 1,689 | Provides skin research, testing, and clinical studies for cosmetic and chemical sectors. | ||
| sciderm.de | 2005 | Hamburg, Germany | CRO focussed exclusively in dermatology, allergology, aesthetic drug development and device certification services |
Detailed competitors of Bioskin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioskin
Complete news archive for Bioskin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioskin
Bioskin was founded in 1992.
Bioskin is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Bioskins service portfolio includes strategic and regulatory consulting for dermatology, ophthalmology and womens health products, early phase safety and Proof-of-Concept studies, vasoconstrictor assays and global Phase II-IV trials for NCEs, new formulations with known actives and generics. They offer services such as efficacyproof of concept, project management, data operations, quality management, and medical writing etc., They claim to maintain a database of patients and healthy volunteers with skin conditions and diseases in Europe. They also claim to have the capability for developing innovative test models and integrating biophysical measurements to deliver data about skin function and structure to support clinical endpoints. They also have partnerships with other companies in US, Latin America, South Africa and few others to conduct multinational studies.
Bioskin's top competitors include SCIderm and SIT Skin Investigation and Technology.
Bioskin offers Dermatologic Consulting, Clinical Development, and Global Trials.
Bioskin has 1 investor. Key investors include Eurofins Scientific.
Bioskin operates through Eurofins Bioskin Gmbh.
Yes. Bioskin was acquired by Eurofins Scientific in August 2021.